ArticleJournal of Yeungnam medical science2026
Trends and disparities in the burden of oral cancer in Southeast Asia, 1990 to 2023: a retrospective analysis based on the Global Burden of Disease 2023 data.
Article in Journal of Yeungnam medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral cancer remains a major global public health issue, particularly in Southeast Asia, where its incidence and mortality rates are the highest worldwide. Malaysia, although a part of Southeast Asia, possesses a more advanced healthcare system, offering a unique comparison for understanding regional disparities. This study aimed to evaluate and compare the burden of oral cancer in Malaysia and Southeast Asia from 1990 to 2023 and forecast future trends using the most recent Global Burden of Disease (GBD) 2023 data.
methodsAge-standardized incidence, mortality, and disability-adjusted life years (DALYs) were extracted from the GBD 2023 database. Joinpoint regression was applied to identify temporal shifts and estimate the annual percent change and average annual percent change. Autoregressive integrated moving average (ARIMA) models were used to predict future trends from 2024 to 2038.
resultsMalaysia has exhibited a largely stable burden of oral cancer over the past three decades, with DALYs increasing by only 2.3% and incidence by 18.0%. In contrast, Southeast Asia experienced substantial increases in DALYs (20.9%), incidence (38.8%), and mortality (14.9%). Marked sex disparities persisted, particularly in Southeast Asia, where males had 1.6× to 2.3× higher burden than females. ARIMA forecasts indicate that Malaysia's oral cancer burden will remain largely stable, whereas Southeast Asia is projected to experience significant increases through 2038.
conclusionMalaysia's relatively stable trends may reflect stronger public health interventions, including tobacco control and improved access to care. In contrast, the continuously rising burden in Southeast Asia underscores the persistent gaps in prevention, early detection, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.